ERD-3111
ERD-3111 (Compound 44) is a potent, orally bioavailable PROTAC that selectively degrades ERα with a DC50 of 0.5 nM. It demonstrates robust anti-tumor activity in vivo against both wild-type and ESR1-mutant ER+ breast cancer models, making it a valuable chemical probe for investigating endocrine resistance mechanisms.
Product Specifications
CAS Number
2832865-25-3
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Smiles
C (C (F) F) N1[C@@H] (C2=C (C3=C (C=C2) NN=C3) C[C@H]1C) C4=C (F) C=C (C=C4F) N5CCC6 (CC5) CCN (C (CN7CC=8C (C7) =CC9=C (C8) C (=O) N (C9=O) C%10C (=O) NC (=O) CC%10) =O) CC6
Molecular Formula
C45H46F4N8O5
Molecular Weight
854.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6384411-01 0.1 mL
LRRFIP1 (Leucine-rich Repeat Flightless-interacting Protein 1, LRR FLII-interacting Protein 1, GC-binding Factor 2, TAR RNA-interacting Protein, GCF2, TRIP) (AP)
Sign In for Pricing
View Details MBS6384411-02 5x 0.1 mL
LRRFIP1 (Leucine-rich Repeat Flightless-interacting Protein 1, LRR FLII-interacting Protein 1, GC-binding Factor 2, TAR RNA-interacting Protein, GCF2, TRIP) (AP)
Sign In for Pricing
View Details 
